Methods of treating hepatic encephalopathy
AssigneeSalix Pharmaceuticals, Inc.
InventorWilliam Forbes
Life of this patent
Estimating the term…
Abstract
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
Claims35
(canceled)
(canceled)
A method of decreasing a subject's risk of a hepatic encephalopathy (HE) breakthrough episode comprising administering rifaximin to a subject suffering from HE.
(canceled)
(canceled)
(canceled)
11-13. (canceled)
A method of maintaining remission of HE in a subject comprising administering rifaximin to a subject suffering from HE.
A method of reducing the frequency of hospitalization visits by an HE patient, comprising administering rifaximin to a subject suffering from HE.
17-19. (canceled)
(canceled)
(canceled)
24-26. (canceled)
(canceled)
30-37. (canceled)
(canceled)
41-46. (canceled)
48-51. (canceled)
53-74. (canceled)
A method of increasing the time between breakthrough events for a patient suffering from hepatic encephalopathy, comprising administering to the patient an effective amount of rifaximin that extends the time between hepatic encephalopathy breakthrough events.
77-96. (canceled)
Dependencies are inferred from the claim text.